Neurobiological Technologies Inc Watch

from 10-K 3 pages Agreement to Terminate the License and Cooperation Agreement With Respect to Neurobiological Technologies, Inc

from 8-K 3 pages Amendment and Addendum to Collaboration and Services Agreement

from 8-K 3 pages Termination Agreement

from 8-K 3 pages Termination Agreement to Master Clinical Services Agreement and Work Order No. 1 and 2

from 10-Q 6 pages Art. 1 Termination of Agreements

from 10-K 1 page Fiscal 2009 Executive Officer Base Salaries and Fiscal 2008 Bonus Amounts

from 10-K 10 pages Form of Indemnity Agreement

from 10-Q 32 pages Collaboration and License Agreement

from 10-Q 30 pages Collaboration and License Agreement

from 10-Q 4 pages Amendment to the License and Cooperation Agreement

from 8-K 4 pages March 18, 2008 Matthew M. Loar [Address] Re: Offer of Employment at Neurobiological Technologies, Inc. Dear Matt

from 8-K 7 pages February 14, 2008 Craig W. Carlson Dear Craig: This Letter Confirms Your Separation From Employment With Neurobiological Technologies, Inc. (The “Company”). This Letter Also Proposes an Agreement Between You and the Company

from 10-K 21 pages Master Clinical Services Agreement by and Between Neurobiological Technologies, Inc. and Icon Clinical Research Limited

from 8-K 32 pages Security Agreement

from 8-K 32 pages Securities Purchase Agreement Dated as of September 12, 2007 by and Among Neurobiological Technologies, Inc. And

from 8-K 8 pages Neurobiological Technologies, Inc. Consulting Agreement

from 8-K 50 pages Securities Purchase Agreement

from 10-Q 37 pages License and Cooperation Agreement

from 10-K 8 pages Pursuant to the Notice of Change Order Document, Signed by Scirex Corporation and Neurobiological Technologies, Dated 21 February 2006, and as Noted Therein That the Details of Some Items in the Change Order Require Further Discussion, Following Represents the Agreement Between Scirex and Nti Regarding the Resolution of Such Outstanding Details. Personnel and Resulting Services to Be Modified or Terminated 1. Reduce Global Director Position by Two-Thirds From the 0.75 Total Fte Estimated in the Proposal A. the Global Project Director Retained by Scirex, Ellen Sargent, Is a Contracted Employee. B. Scirex Will Terminate Her Contract for Services Associated With Nti Protocols 0502 and 0503 as of 31 March 2006. C. Nti Is Free to Pursue a Contract With Ms. Sargent Following 31 March 2006. D. Nti Will Incur No Further Charges Beyond 31 March 2006 for the Services of a Global Project Director Provided by Scirex. 2. Eliminate Project Managers (US and Row) A. No Further Services Associated With Activities in the United States for Nti Protocols 0502 and 0503 Will Be Performed by Scirex Project Managers Following 31 January 2006. B. No Further Services Associated With Project Management Activities in South Africa for Nti Protocols 0502 and 0503 Will Be Furnished by Scirex Following 31 March 2006. C. Scirex Will No Longer Retain the Services of Novotech for Project Management Activities in Australia and New Zealand Following 31 March 2006. D. Nti Is Free to Pursue a Contract With Novotech for Project Management Activities in Australia and New Zealand Following 31 March 2006. E. Nti Will Incur No Further Charges Beyond 31 January 2006 for the Services of a Project Managers Provided by Scirex. 3. Eliminate Lead Cras A. No Further Services Associated With Activities for Nti Protocols 0502 and 0503 Will Be Performed by Scirex Lead Cras Following 31 March 2006. B. Nti Will Incur No Further Charges Beyond 31 March 2006 for the Services of Lead Cras Provided by Scirex

from 10-K 9 pages Amendment of the Agreement on the Establishment of a Snake Farm and Purification Unit the Following New Version of the Article 6 Replaces Article 6 From 6.1 to 6.7 of the Agreement Signed January 18, 2006 Article 6 Financial Obligations of the Parties